-
In this issue: FDA is reviewing safety of TZDs; SSRI use with tamoxifen; Metformin smells like fish; FDA Actions.
-
-
-
In a recent issue of OB/GYN Clinical Alert (see the November 2009 issue), a special feature was devoted to the contemporary antepartum management of twin pregnancies.
-
Endometrial cancer is the most common gynecologic malignancy and most often presents with corpus-limited disease.
-
Results from new research of a theory-based, abstinence-only intervention appear to be associated with a lower rate of sexual involvement among African American sixth- and seventh-graders.
-
Findings from a new study identify women at higher risk of significant bone loss on injectable birth control.
-
Family planning clinicians are familiar with the hormones that regulate human reproduction. Research has identified a new hormone that suppresses reproduction, which opens the door to possible development of a new class of contraceptive.
-
For women who request emergency contraception, ulipristal acetate might be an effective alternative to levonorgestrel, according to results of a new study.
-
HIV-positive women have a much higher risk of developing cervical and uterine cancers than do women without the disease, due to their impaired immune function.
